Amoxicillin & Potassium Clavulanate Oral Suspension 228.5 mg Manufacturer & Exporter
Wellona Pharma is a leading Amoxicillin & Potassium Clavulanate Oral Suspension 228.5 mg manufacturer and exporter in India, supplying quality pharmaceutical formulations to global markets. Marketed under the brand Wellmoxy CV, this antibiotic suspension combines Amoxicillin with Potassium Clavulanate to treat susceptible bacterial infections.
Uses
Amoxicillin & Potassium Clavulanate Oral Suspension 228.5 mg may be prescribed for bacterial infections affecting the ear, nose, throat, respiratory tract, urinary tract, skin, soft tissues, and dental areas. It should be used only as directed by a qualified healthcare professional.
Advantages
The combination provides broad-spectrum antibacterial activity. Potassium Clavulanate inhibits certain beta-lactamase enzymes, helping Amoxicillin remain effective against susceptible beta-lactamase-producing bacteria. The oral suspension dosage form also provides convenient administration, particularly when a liquid formulation is preferred.
Disadvantages / Side Effects
Common side effects may include diarrhea, nausea, vomiting, stomach discomfort, and skin rash. Allergic reactions can occur in patients sensitive to penicillin or related antibiotics. This medicine does not treat viral infections and should not be used without appropriate medical advice.
As a trusted Amoxicillin & Potassium Clavulanate Oral Suspension manufacturer, exporter and supplier, Wellona Pharma serves pharmaceutical importers, distributors, wholesalers and institutional buyers worldwide with reliable packaging and international export support.